Publication: Medical Device Daily

First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

TCT 2014: Doc says 40-year old patient may be better off in long run with TAVR

WASHINGTON The course of disease is not always taken into account as a novel technology enters routine use, but Michael Mack, the famed cardiac surgeon from Baylor Heart Center (Dallas), suggested that one way to minimize the number of surgeries for ... [Published Medical Device Daily - Sep 19 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

TCT 2014: BVS outcomes seen as satisfactory, but DES still superior at 12 months

It can scarcely be claimed the drug-eluting cardiovascular stent wars are over, but Abbott Vascular (Temecula, California) now has its bioresorbable vascular scaffold (BVS) in the fight, as the Everbio II trial makes clear. Lead investigator Stéphane ... [Published Medical Device Daily - Sep 18 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Early data from ABSORB II seem iffy; device curvature 'better than expected'

WASHINGTON Abbott Vascular (Temecula, California), held center stage for much of the morning Sept. 14 sessions at TCT 2014 thanks in part to publication of early data from the Absorb II trial matching the company's BVS bioresorbable stent against the ... [Published Medical Device Daily - Sep 17 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

26th TCT symposium in Washington: Economist says docs should be up in arms over payer admin duplication

WASHINGTON Princeton University (Princeton, New Jersey) economist Uwe Reinhardt is hardly known for reticence, and he did not disappoint attendees at the first full day's proceedings at TCT 2014, taking square aim at a number of entities inside and outside ... [Published Medical Device Daily - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

UVA doctors explore image-guided, high-dose approach to breast cancer

Doctors at the University of Virginia Health System (Charlottesville) are exploring a new approach to breast cancer treatment that allows them to administer significantly higher doses of cancer-killing radiation where it's needed at the same time as tumor ... [Published Medical Device Daily - Sep 15 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

Blood test shows promise in fight against colorectal cancer

Patient compliance to current screening methods has long been cited as the antagonistic force in the fight against colorectal cancer. Even with all the evidence pointing to early detection through colonoscopy being the key to survival, patients too often ... [Published Medical Device Daily - Sep 12 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

FDA clears new biomarker test from Astute Medical for acute kidney injury

A new test used to assess risk for acute kidney injury (AKI) could help doctors significantly improve management of ICU patients and reduce costs to the healthcare system. Astute Medical (San Diego) said it has received FDA 510(k) clearance for its first ... [Published Medical Device Daily - Sep 10 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

Daily M&A: Cynosure acquires assets of Ellman for $13.2 million cash

Cynosure (Westford, Massachusetts), a provider of laser- and light-based aesthetic treatments, said it has acquired the assets of Ellman International (Hicksville, New York) for about $13.2 million in cash. Ellman develops advanced radio frequency (RF) ... [Published Medical Device Daily - Sep 09 2014]
First reported Sep 06 2014 - Updated Sep 06 2014 - 1 reports

Report from Europe: Company mum as second implant reported for Carmat artificial heart

PARIS In early August 2014 a patient at the University Hospital Center (CHU) in Nantes, France, received an artificial heart made by Carmat (Paris) in a surgical procedure lead by Daniel Duveau, according to the daily Paris-based newspaper Liberatio ... [Published Medical Device Daily - Sep 06 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

NewCo on the Go: Fractyl raises $40M to develop new endoscopic procedure for diabetes

When most people think about diabetes therapy they think of insulin or other pharmaceutical approaches. But new understanding of Type 2 diabetes has inspired one young company to develop a procedure aimed at the underlying digestive causes of the disease. ... [Published Medical Device Daily - Sep 05 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

European Society of Cardiology 2014: St Jude's FFR technology has impact on patients suffering from NSTEMI

A new study from St. Jude Medical (St. Paul, Minnesota) is breathing new life into the company's Fractional Flow Reserve (FFR) technology. The company reported results from a new multi-center clinical trial that has found that using its PressureWire FFR ... [Published Medical Device Daily - Sep 03 2014]
First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Kona stakes claim in renal denervation space with WAVE IV clinical trial

Another company is staking its claim in developing a non-invasive approach toward treating hypertension. Kona Medical (Bellevue, Washington) is evaluating its Surround Sound Hypertension Therapy System through the WAVE IV clinical trial. The randomized, ... [Published Medical Device Daily - Sep 01 2014]

Quotes

One of three with echo "had moderate to severe" regurgitation, which dropped to 12%-15% with CT sizing, Piazza said, adding, "it becomes more important in these patients to size these valves" properly, especially since the devices are not designed to deal with a bicuspid valve
"The results of the Premium trial are eagerly awaited to see if they confirm or refute" the Prima trial's outcome, Hildick-Smith said of the 230-subject study of the Amplatzer
...Both arms of the study "are exactly equal in terms of the peri-procedural MI rate" he argued, asserting that the SCAI definition is "the most clinically relevant definition."

More Content

All (24) | News (24) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
TCT 2014: Doc says 40-year old patient may be b... [Published Medical Device Daily - Sep 19 2014]
TCT 2014: BVS outcomes seen as satisfactory, bu... [Published Medical Device Daily - Sep 18 2014]
Early data from ABSORB II seem iffy; device cur... [Published Medical Device Daily - Sep 17 2014]
26th TCT symposium in Washington: Economist say... [Published Medical Device Daily - Sep 15 2014]
UVA doctors explore image-guided, high-dose app... [Published Medical Device Daily - Sep 15 2014]
Blood test shows promise in fight against color... [Published Medical Device Daily - Sep 12 2014]
FDA clears new biomarker test from Astute Medic... [Published Medical Device Daily - Sep 10 2014]
Daily M&A: Cynosure acquires assets of Ellman f... [Published Medical Device Daily - Sep 09 2014]
Report from Europe: Company mum as second impla... [Published Medical Device Daily - Sep 06 2014]
NewCo on the Go: Fractyl raises $40M to develop... [Published Medical Device Daily - Sep 05 2014]
European Society of Cardiology 2014: St Jude's ... [Published Medical Device Daily - Sep 03 2014]
Kona stakes claim in renal denervation space wi... [Published Medical Device Daily - Sep 01 2014]
NewCo on the Go: MetaStat's summer: new financi... [Published Medical Device Daily - Aug 29 2014]
Daily M&A: Medtronic stays hot on M&A path with... [Published Medical Device Daily - Aug 28 2014]
Venture capital soars in med-tech space accordi... [Published Medical Device Daily - Aug 27 2014]
FDA approves Medtronic Viva CRT-P for HF with A... [Published Medical Device Daily - Aug 26 2014]
Robotic Exoskeletons: Exoskeleton's greatest hu... [Published Medical Device Daily - Aug 23 2014]
Robotic Exoskeletons: Quartet of players stake ... [Published Medical Device Daily - Aug 22 2014]
ReWalk's clearance puts exoskeleton technology ... [Published Medical Device Daily - Aug 21 2014]
Financings: HQC closes debut fund at $110M to i... [Published Medical Device Daily - Aug 20 2014]
Abbott joins forces with DOD for concussion blo... [Published Medical Device Daily - Aug 19 2014]
Bioengineers create 3-D brain-like tissue, dubb... [Published Medical Device Daily - Aug 16 2014]
Second Sight sets sights on $32M IPO for implan... [Published Medical Device Daily - Aug 15 2014]
First U.S. commercial Neuraceq scan for beta-am... [Published Medical Device Daily - Aug 14 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.